Related Experiment Videos
Beta2-adrenoceptors facilitating noradrenaline secretion from human vasoconstrictor nerves
Acta Physiologica Scandinavica
|March 1, 1976
Summary
Beta-adrenoceptors on human blood vessels regulate noradrenaline (NA) secretion. Studies show these receptors are primarily beta2-adrenergic, influencing neurotransmitter release from vasoconstrictor nerves.
Area of Science:
- Pharmacology
- Neuroscience
- Cardiovascular Biology
Background:
- Beta-adrenoceptors modulate neurotransmitter secretion from adrenergic nerves.
- Previous research suggested beta-adrenoceptors increase 3H-noradrenaline (NA) secretion in human peripheral vessels.
Purpose of the Study:
- To investigate the specific subtypes of beta-adrenoceptors controlling NA secretion from human peripheral arteries and veins.
- To determine the role of these receptors in the local feedback control of neurotransmitter release.
Main Methods:
- Human peripheral artery and vein biopsy specimens were preincubated with 3H-noradrenaline to label neural stores.
- Electrical field stimulation was used to evoke 3H-NA secretion.
- The effects of various beta-adrenergic agonists and antagonists (isoprenaline, propranolol, selective beta1 and beta2 antagonists) on 3H-NA secretion were examined.
Main Results:
- Isoprenaline-induced increase in 3H-NA secretion was blocked by propranolol.
- Beta1-agonists did not affect 3H-NA secretion, while beta2-agonists increased it dose-dependently.
- Selective beta1-antagonists had no effect, but beta2-blocking drugs reduced isoprenaline's effect on 3H-NA secretion.
- Propranolol alone slightly decreased basal 3H-NA secretion.
Conclusions:
- The beta-adrenoceptors controlling NA secretion from human omental blood vessel vasoconstrictor nerves are predominantly beta2-adrenergic.
- These beta2-adrenoceptors are minimally stimulated by the released NA, suggesting they do not primarily mediate local positive feedback control of transmitter secretion.